Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled trial of Bufei Huoxue capsule in COPD with qi deficiency and blood stasis syndrome
CTR20260784Phase 3Active
- Sponsor
- Lei Yun Shang (Guangdong)
- Start
- Apr 2026
- Countries
- 1
01
Overview
A Phase 3 trial of bufei huoxue in chronic obstructive pulmonary disease (COPD), sponsored by Lei Yun Shang (Guangdong). Started Apr 2026; status: active.
02
Drugs
bufei huoxue
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20260784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260784.